|Oral rivaroxaban for symptomatic venous thromboembolism.|
G Agnelli, S Berkowitz, H Bounameaux, H Büller, A Cohen, A Gallus, ...
N Engl J Med 363 (26), 2499-510, 2010
|Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home|
MMW Koopman, P Prandoni, F Piovella, PA Ockelford, DPM Brandjes, ...
New England Journal of Medicine 334 (11), 682-687, 1996
|Apixaban for extended treatment of venous thromboembolism|
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, A Porcari, ...
New England Journal of Medicine, 2012
|Extended use of dabigatran, warfarin, or placebo in venous thromboembolism|
S Schulman, C Kearon, AK Kakkar, S Schellong, H Eriksson, D Baanstra, ...
New England Journal of Medicine 368 (8), 709-718, 2013
|D-dimer testing to determine the duration of anticoagulation therapy|
G Palareti, B Cosmi, C Legnani, A Tosetto, C Brusi, A Iorio, V Pengo, ...
New England Journal of Medicine 355 (17), 1780-1789, 2006
|Low-molecular weight heparin in the treatment of patients with venous thromboembolism: the Columbus Investigators|
HR Buller, M Gent, AS Gallus, J Ginsberg, MH Prins, R Baildon, ...
The New England journal of medicine 337, 657-662, 1997
|Aspirin for Preventing the Recurrence of Venous Thromboembolism|
C Becattini, G Agnelli, A Schenone, S Eichinger, E Bucherini, M Silingardi, ...
New England Journal of Medicine 366 (21), 1959-1967, 2012
|Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis|
S Siragusa, B Cosmi, F Piovella, J Hirsh, JS Ginsberg
The American journal of medicine 100 (3), 269-277, 1996
|Cardiovascular events and intensity of treatment in polycythemia vera|
R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ...
New England Journal of Medicine 368 (1), 22-33, 2013
|Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study|
A Cogo, AWA Lensing, MMW Koopman, F Piovella, S Siragusa, PS Wells, ...
Bmj 316 (7124), 17-20, 1998
|Rivaroxaban for thromboprophylaxis in acutely ill medical patients|
AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ...
New England Journal of Medicine 368 (6), 513-523, 2013
|Fondaparinux for the treatment of superficial-vein thrombosis in the legs|
H Decousus, P Prandoni, P Mismetti, RM Bauersachs, Z Boda, B Brenner, ...
New England Journal of Medicine 363 (13), 1222-1232, 2010
|Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled …|
E Bernardi, G Camporese, HR Büller, S Siragusa, D Imberti, A Berchio, ...
Jama 300 (14), 1653-1659, 2008
|Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review|
A Iorio, C Kearon, E Filippucci, M Marcucci, A Macura, V Pengo, ...
Archives of internal medicine 170 (19), 1710-1716, 2010
|Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry|
P Knoebl, P Marco, F Baudo, P Collins, A Huth‐Kühne, L Nemes, ...
Journal of Thrombosis and Haemostasis, 2012
|Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)|
HKA Collins P, Baudo F, Knoebl P, Lévesque H, Nemes L, ...
blood 120 (1), 47-55, 2012
|Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression …|
S Siragusa, A Malato, R Anastasio, V Cigna, G Milio, C Amato, M Bellisi, ...
Blood 112 (3), 511-515, 2008
|Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial|
MA Crowther, W Ageno, D Garcia, L Wang, DM Witt, NP Clark, ...
Annals of internal medicine 150 (5), 293-300, 2009
|The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study|
P Prandoni, S Siragusa, B Girolami, F Fabris
Blood 106 (9), 3049-3054, 2005
|Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients|
D Caramazza, KH Begna, N Gangat, R Vaidya, S Siragusa, DL Van Dyke, ...
Leukemia 25 (1), 82, 2011